Discussions

single cell genomics​ is a fast growing subject that is shedding new light on a wide range of complex biological systems, from the diversity of the microbial ecosphere to the genomics of human cancer. By physically separating chromosomes to reduce the complexity of genomic signals, single-cell omics technology now offers a higher-resolution picture of the genomic content of specimens.

Christensenella minuta is a recently described gastrointestinal bacterium that plays a significant role in the prevention of obesity. Here, Creative Biolabs provides a comprehensive range of high-quality services and support for the development of probiotics based on Christensenella minuta.

With years of experience in the development of LBPs, Creative Biolabs prides itself on being an innovator and problem solver in LBPs. We offer high-quality potential probiotic strains with award-winning high quality, and perfect customer services that save customers time, money, and stress. When you choose Creative Biolabs as your culture suppler, our experts will guide you through the product research process.

_Bifidobacterium bifidum (B. bifidum) usually represent the most abundant bacteria in the human intestinal flora of healthy breast-fed infants. It shows significant physiological and genetic characteristics, including adhesion to the epithelium and the metabolism of host-derived glycans. Taking advantage of the specific adaptability of B. bifidum to human intestines and its significance in supporting host health, Creative Biolabs launched the drug discovery service for probiotics B. bifidum.

Next generation probiotics (NGPs), also referred to live biotherapeutic products (LBPs), can target specific diseases and can be used as a revolutionary class of medicines for therapeutic purposes. NGPs are usually derived from next-generation sequencing (NGS) and bioinformatics analysis. With our state-of-the-art technology and industry-leading expertise, Creative Biolabs has developed an unparalleled platform for NGP isolation, identification, and functional characterization. Currently, we have discovered a wide range of potential NGPs, including Akkermansia muciniphila strain, for pre-clinical, clinical, and commercial applications.

Alzheimer's disease (AD) is one of the most concerning neurodegenerative diseases. As a global leading CRO company focusing on neuroscience research, Creative Biolabs has an advanced technology platform providing various kinds of AD in vitro disease model services to help accelerate AD studies.

Creative Biolabs is the specialist provider of an AD biomarker assay. We have a professional team of scientists to provide a comprehensive range of rapid AD Biomarker assays through standard experimental procedures to meet the different needs of AD research.

Creative Biolabs is always the leader in 3D neural spheroids culture technology services and offers a variety of technologies to help you grow 3D neural spheroids quickly and efficiently. In addition, we also provide functional tests and a one-stop service for your research and development to bring more physiological relevance.